About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Multicenter CTS Pre-and Post-Transplantation Covid-19 Serum Studies

NCT04694573·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Caner Suesal, Professor
CONTACT
+49 (0) 6221 56-5545 [email protected]
Christian Morath, Professor
CONTACT
+49 (0) 6221 91120 [email protected]

Lead

Heidelberg University

Age

18–75

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Kidney-transplant recipients and full-size liver-recipients (de-novo or re-transplanted)
Participant or legal guardian is willing and able to give informed consent for participation in the trial
SARS-CoV-2 infection before transplantation (PRE-TX Covid-19 Serum Study) or after transplantation (POST-TX Covid-19 Serum Study)
Kidney or liver transplantation between Dec 17,2020 - Dec 17, 2021
Hospitalization due to SARS-CoV-2 infection in between Dec 17,2020 - Dec 17, 2021
multi-organ transplant recipients

The record

StatusUnknown

PhaseNo phase

Taking part600

StartedDec 2020

UpdatedJan 19, 2021

Conditions

Covid19 Kidney Transplant; Complications Kidney Transplant Failure and Rejection Liver Transplant; Complications Liver Transplant Failure and Rejection

Where1

Nierenzentrum Heidelberg
Heidelberg, DE, Germany

Clareo Health | Multicenter CTS Pre-and Post-Transplantation Covid-19 Serum Studies